Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SENORES.NSthis companySenores Pharmaceuticals Ltd.	₹1,175.00	29.36×	3.63×	5.35×	17.1×	-1427.7%	60.2%	21.7%	18.2%	12.4%	8.0%	-6.0%	0.37×	1.38×	5.48×	1.92×	0.0%	—	—	2	B-
AJANTPHARM.NSAjanta Pharma Limited	₹3,344.00	33.18×	7.74×	6.43×	22.46×	64.5%	51.4%	24.3%	19.4%	23.3%	20.5%	0.4%	0.06×	0.1×	82.23×	2.64×	1.0%	5	18.51	4	A
BLISSGVS.NSBliss GVS Pharma Limited	₹654.75	18.76×	2.03×	2.61×	10.25×	-99.6%	54.2%	14.1%	13.9%	10.8%	7.3%	3.4%	0.02×	-0.06×	10.87×	4.02×	0.4%	6	17.76	3	B
DRREDDY.NSDr. Reddy's Laboratories Limited	₹1,385.00	24.38×	2.77×	3.11×	14.13×	25.1%	52.8%	13.8%	12.8%	11.4%	7.5%	2.9%	0.24×	0.94×	12.42×	1.8×	0.6%	7	5.66	3	B+
INNOVACAP.NSInnova Captab Limited	₹1,068.90	28.01×	3.62×	2.46×	20.43×	-208.4%	32.6%	10.3%	8.8%	12.9%	8.4%	0.9%	0.32×	1.62×	9.74×	1.87×	0.3%	4	—	2	C
JAGSNPHARM.NSJagsonpal Pharmaceuticals Limited	₹217.42	29.01×	4.53×	4.35×	18.35×	83.7%	63.7%	16.9%	15.0%	15.6%	12.6%	3.7%	0.03×	-0.03×	47.31×	5.06×	1.3%	5	13.66	4	A
Peer median	—	28.01×	3.62×	3.11×	18.35×	25.1%	52.8%	14.1%	13.9%	12.9%	8.4%	2.9%	0.06×	0.1×	12.42×	2.64×	0.6%	5	15.71	3	—